Previous studies have shown that N1-methylnicotinamide (MNAM) regulates insulin sensitivity and hepatocyte gluconeogenesis in mice with type 2 diabetes by activating SIRT1 and inhibiting the acetylation of FOXO1 [32]. Here, INS is linked to type 2 diabetes mellitus.